{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T03:43:19Z","timestamp":1769312599892,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1124\/jpet.110.165852","type":"journal-article","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T01:10:13Z","timestamp":1272589813000},"page":"410-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Sulindac and Its Metabolites Inhibit Multiple Transport Proteins in Rat and Human Hepatocytes"],"prefix":"10.1016","volume":"334","author":[{"given":"Jin Kyung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary F.","family":"Paine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim L.R.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.110.165852_bib1","doi-asserted-by":"crossref","unstructured":"Aithal GP, Day CP (2007) Nonsteroidal anti-inflammatory drug-induced hepatotoxicity. Clin Liver Dis 11:563\u2013575, vi\u2013vii.","DOI":"10.1016\/j.cld.2007.06.004"},{"key":"10.1124\/jpet.110.165852_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0026-895X(25)13032-0","article-title":"Multiple carriers for uptake of [3H]estradiol-17 \u03b2(\u03b2-d-glucuronide) in isolated rat hepatocytes","volume":"32","author":"Brouwer","year":"1987","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.110.165852_bib3","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.110.165852_bib4","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.110.165852_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/bdd.2510040407","article-title":"Biliary secretion of sulindac and metabolites in man","volume":"4","author":"Dobrinska","year":"1983","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/jpet.110.165852_bib6","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/0006-2952(78)90137-5","article-title":"Comparative disposition of sulindac and metabolites in five species","volume":"27","author":"Duggan","year":"1978","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.110.165852_bib7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/clpt.1983.26","article-title":"Enterohepatic circulation of sulindac and metabolites","volume":"33","author":"Dujovne","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.110.165852_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/jpet.106.110379","article-title":"Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2\/ABCC2- and MRP4\/ABCC4-mediated methotrexate transport","volume":"320","author":"El-Sheikh","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.165852_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1067\/mcp.2001.114667","article-title":"The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions","volume":"69","author":"Fattinger","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.110.165852_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0300-483X(01)00460-7","volume":"167","author":"Funk","year":"2001","journal-title":"Toxicology"},{"key":"10.1124\/jpet.110.165852_bib11","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/jps.2600790907","article-title":"Effect of aspirin and sulindac on methotrexate clearance","volume":"79","author":"Furst","year":"1990","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.110.165852_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0006-2952(00)00301-4","article-title":"Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases. Comparison of human liver and kidney microsomes and mammalian enzymes","volume":"60","author":"Hamman","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.110.165852_bib13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1177\/0091270007312153","article-title":"New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process","volume":"48","author":"Huang","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.110.165852_bib14","first-page":"611","article-title":"C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance","volume":"1","author":"Imai","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/jpet.110.165852_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0031-6997(24)01372-3","article-title":"Prediction of pharmacokinetic alterations caused by drug\u2013drug interactions: metabolic interaction in the liver","volume":"50","author":"Ito","year":"1998","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.110.165852_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/toxsci\/kfi020","article-title":"Xenobiotics inhibit hepatic uptake and biliary excretion of taurocholate in rat hepatocytes","volume":"83","author":"Kemp","year":"2005","journal-title":"Toxicol Sci"},{"key":"10.1124\/jpet.110.165852_bib17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1124\/jpet.102.037580","article-title":"Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs","volume":"303","author":"Khamdang","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.165852_bib18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/00498250802040584","article-title":"Bile acid transporters in health and disease","volume":"38","author":"Kosters","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.110.165852_bib19","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-3565(24)37686-4","article-title":"Contribution of sodium taurocholate cotransporting polypeptide to the uptake of its possible substrates into rat hepatocytes","volume":"286","author":"Kouzuki","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.165852_bib20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-3565(24)37999-6","article-title":"Contribution of organic anion transporting polypeptide to uptake of its possible substrates into rat hepatocytes","volume":"288","author":"Kouzuki","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.165852_bib21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0016-5085(86)90921-2","article-title":"Altered renal and platelet arachidonic acid metabolism in cirrhosis","volume":"90","author":"Laffi","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.110.165852_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1124\/jpet.109.156653","article-title":"Hepatobiliary disposition of troglitazone and metabolites in rat and human sandwich-cultured hepatocytes: use of Monte Carlo simulations to assess the impact of changes in biliary excretion on troglitazone sulfate accumulation","volume":"332","author":"Lee","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.165852_bib23","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/jpet.106.119073","article-title":"Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP\/SLC10A1) by bosentan: a mechanism for species differences in hepatotoxicity","volume":"321","author":"Leslie","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.165852_bib24","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1021\/mp900044x","article-title":"Quantitative expression profile of hepatobiliary transporters in sandwich cultured rat and human hepatocytes","volume":"6","author":"Li","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.110.165852_bib25","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/S0022-3565(24)38310-7","article-title":"Use of Ca2+ modulation to evaluate biliary excretion in sandwich-cultured rat hepatocytes","volume":"289","author":"Liu","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.165852_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00280-004-0931-x","article-title":"Single nucleotide polymorphisms modify the transporter activity of ABCG2","volume":"56","author":"Morisaki","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/jpet.110.165852_bib27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2003.50331","article-title":"Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane","volume":"38","author":"Rius","year":"2003","journal-title":"Hepatology"},{"key":"10.1124\/jpet.110.165852_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2133\/dmpk.18.33","article-title":"Function of uptake transporters for taurocholate and estradiol 17\u03b2-d-glucuronide in cryopreserved human hepatocytes","volume":"18","author":"Shitara","year":"2003","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/jpet.110.165852_bib29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0022-3565(24)29383-6","article-title":"Characterization of the efflux transport of 17\u03b2-estradiol-d-17\u03b2-glucuronide from the brain across the blood-brain barrier","volume":"298","author":"Sugiyama","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.165852_bib30","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0016-5085(93)90428-F","article-title":"Sulindac-associated hepatic injury: analysis of 91 cases reported to the Food and Drug Administration","volume":"104","author":"Tarazi","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.110.165852_bib31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0167-4838(83)90125-5","article-title":"Sulfoxide reductase activity of liver aldehyde oxidase","volume":"747","author":"Tatsumi","year":"1983","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.110.165852_bib32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1365-2125.2003.01881.x","article-title":"Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver","volume":"56","author":"Wilson","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.110.165852_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.clpt.6100459","article-title":"Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humans","volume":"84","author":"Yamasaki","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.110.165852_bib34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1021\/mp800100e","article-title":"Knocking down breast cancer resistance protein (Bcrp) by adenoviral vector-mediated RNA interference (RNAi) in sandwich-cultured rat hepatocytes: a novel tool to assess the contribution of Bcrp to drug biliary excretion","volume":"6","author":"Yue","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.110.165852_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2006.05.010","article-title":"Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males","volume":"373","author":"Zhang","year":"2006","journal-title":"Clin Chim Acta"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524459302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524459302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.110.165852","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:16:09Z","timestamp":1740017769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524459302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0022356524459302"],"URL":"https:\/\/doi.org\/10.1124\/jpet.110.165852","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sulindac and Its Metabolites Inhibit Multiple Transport Proteins in Rat and Human Hepatocytes","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.110.165852","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}